Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
BMC Biomedical Engineering|September 9, 2020
Developing preclinical models of neuroblastoma: driving therapeutic testingKimberly J Ornell, Jeannine M CoburnJournal of Biomedical Materials Research. Part A|November 30, 2020
Development of a dinutuximab delivery system using silk foams for GD2 targeted neuroblastoma cell deathKimberly J Ornell, Bill Chiu, Jeannine M CoburnJournal of Biomedical Nanotechnology|January 19, 2018
Modulation of MicroRNAs 34a and 21 Affects Viability, Senescence, and Invasion in Glioblastoma MultiformeYuan Yin, Kimberly J Ornell, Alexander Beliveau, et al.Journal of Materials Chemistry. B|February 20, 2020
Controlling methacryloyl substitution of chondroitin sulfate: injectable hydrogels with tunable long-term drug release profilesKimberly J Ornell, Danilo Lozada, Nhi V Phan, et al.Biomaterials Science|December 18, 2020
Development of a stacked, porous silk scaffold neuroblastoma model for investigating spatial differences in cell and drug responsivenessKimberly J Ornell, Katelyn S Mistretta, Coulter Q Ralston, et al.Molecules (Basel, Switzerland)|February 22, 2020
Silk Particle Production Based on silk/PVA Phase Separation Using a Microfabricated Co-flow DeviceNatalia Vargas Montoya, Rachel Peterson, Kimberly J Ornell, et al.ACS Biomaterials Science & Engineering|January 11, 2021
Three-Dimensional, Scaffolded Tumor Model to Study Cell-Driven Microenvironment Effects and Therapeutic ResponsesKimberly J Ornell, Katelyn S Mistretta, Emily Newman, et al.Cancer Medicine|February 26, 2020
Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma modelKimberly J Ornell, Jordan S Taylor, Jasmine Zeki, et al.Annals of Surgical Oncology|June 6, 2021
Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine TumorsXavier M Keutgen, Kimberly J Ornell, Alyx Vogle, et al.Cancer Discovery|September 20, 2017
A Transposon Screen Identifies Loss of Primary Cilia as a Mechanism of Resistance to SMO InhibitorsXuesong Zhao, Ekaterina Pak, Kimberly J Ornell, et al.Pageof 2